These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24614496)

  • 1. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
    Zhu H; Wang X; Wallack M; Li H; Carreras I; Dedeoglu A; Hur JY; Zheng H; Li H; Fine R; Mwamburi M; Sun X; Kowall N; Stern RA; Qiu WQ
    Mol Psychiatry; 2015 Feb; 20(2):252-62. PubMed ID: 24614496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
    Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
    Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts.
    Mousa YM; Abdallah IM; Hwang M; Martin DR; Kaddoumi A
    Sci Rep; 2020 Feb; 10(1):3751. PubMed ID: 32111883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.
    Qiu WQ; Wallack M; Dean M; Liebson E; Mwamburi M; Zhu H
    PLoS One; 2014; 9(2):e88063. PubMed ID: 24520345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Kipiani K; Yu F; Wille E; Katz M; Calingasan NY; Gouras GK; Lin MT; Beal MF
    J Alzheimers Dis; 2011; 27(1):211-23. PubMed ID: 21799249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    Patrick S; Corrigan R; Grizzanti J; Mey M; Blair J; Pallas M; Camins A; Lee HG; Casadesus G
    J Alzheimers Dis; 2019; 69(1):157-168. PubMed ID: 30958347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
    Kimura R; Devi L; Ohno M
    J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
    Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
    J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons.
    Gan Q; Yao H; Na H; Ballance H; Tao Q; Leung L; Tian H; Zhu H; Wolozin B; Qiu WQ
    J Alzheimers Dis; 2019; 70(4):1025-1040. PubMed ID: 31306122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
    Wang E; Zhu H; Wang X; Gower AC; Wallack M; Blusztajn JK; Kowall N; Qiu WQ
    J Alzheimers Dis; 2017; 56(1):47-61. PubMed ID: 27911303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.